Francesco Pisani

4PUBLICATIONS
43CO-AUTHORS
NeonatologyMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 08, 2025
Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy.

Tiziana Bruno, Maria Chiara Cappelletto, Clelia Cortile

|Jan 05, 2024
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.

Annarita Conconi, Annalisa Chiappella, Andrés J M Ferreri

|Jun 06, 2022
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma.

Luca Bertamini, Stefania Oliva, Delia Rota-Scalabrini

Pageof 1